Lite Strategy, Inc. Derivative Liability
Lite Strategy, Inc. (LITS) had Derivative Liability of $423.00 thousand as of 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2014-09-09
- 2011-09-30: Derivative Liability $423.00K.
- 2011-06-30: Derivative Liability $1.10M; Derivative Liability as first filed $1.13M.
- 2011-05-31: Derivative Liability $1.20M; Derivative Liability as first filed $1.17M.
| Period end | Derivative Liability | Derivative Liability as first filed |
|---|---|---|
| 2011-09-30 | $423.00K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $1.10M 10-K · filed 2014-09-09 | $1.13M 10-Q · filed 2011-11-14 |
| 2011-05-31 | $1.20M 10-K · filed 2014-09-09 | $1.17M 10-K · filed 2012-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |